Cargando…
FOXA2 controls the anti-oxidant response in FH-deficient cells
Hereditary leiomyomatosis and renal cell cancer (HLRCC) is a cancer syndrome caused by inactivating germline mutations in fumarate hydratase (FH) and subsequent accumulation of fumarate. Fumarate accumulation leads to profound epigenetic changes and the activation of an anti-oxidant response via nuc...
Autores principales: | Rogerson, Connor, Sciacovelli, Marco, Maddalena, Lucas A., Pouikli, Andromachi, Segarra-Mondejar, Marc, Valcarcel-Jimenez, Lorea, Schmidt, Christina, Yang, Ming, Ivanova, Elena, Kent, Joshua, Mora, Ariane, Cheeseman, Danya, Carroll, Jason S., Kelsey, Gavin, Frezza, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391629/ https://www.ncbi.nlm.nih.gov/pubmed/37405921 http://dx.doi.org/10.1016/j.celrep.2023.112751 |
Ejemplares similares
-
Fumarate hydratase (FH) and cancer: a paradigm of oncometabolism
por: Valcarcel-Jimenez, Lorea, et al.
Publicado: (2023) -
HIRA loss transforms FH-deficient cells
por: Valcarcel-Jimenez, Lorea, et al.
Publicado: (2022) -
Epigenetic alterations in stem cell ageing—a promising target for age-reversing interventions?
por: Pouikli, Andromachi, et al.
Publicado: (2021) -
Oncometabolites: Unconventional triggers of oncogenic signalling cascades
por: Sciacovelli, Marco, et al.
Publicado: (2016) -
Fumarate drives EMT in renal cancer
por: Sciacovelli, Marco, et al.
Publicado: (2017)